Press Release: Viriom : Viriom donates Elpida to Chinese and Russian governments for experimental use against COVID-19; also working with global health authorities to determine the efficacy and safety of Elpida and its other clinical candidates AV5080, AV5124 and AV5126 against COVID-19
/PRNewswire/ -- Viriom Inc today announces the company's activities to address the COVID-19 public health crisis, including supporting the experimental use of...
Read full article »
Viriom is a biotech company that develops and commercializes novel therapies for the treatment of life threatening infections such as HIV and HBV.
Read more